目的研究东菱克栓酶治疗进展性脑血栓的疗效。方法全部病例按顺序随机分成治疗组与常规治疗组各24例。前者除常规治疗外,应用了东菱克栓酶治疗。结果东菱克栓酶可阻止症状进一步恶化,在短期内改善伤残程度,且无明显不良反应,至28d显效率分别为63%和13%,有效率分别为86%和36%,两组比较均有极显著差异(P<0.01)。结论东菱克栓酶为治疗进展性脑血栓安全、有效的药物。 Objective To study the curative effect of rhubarb thrombin in patients with progressive cerebral thrombosis. Methods All cases were randomly divided into treatment group and conventional treatment group, 24 cases each. In addition to the former conventional treatment, the application of the East Ling Keke enzyme treatment. Results Batroxobin could prevent further deterioration of symptoms and improve disability in the short term with no obvious adverse reactions. The effective rates were 63% and 13% respectively at 28 days, and the effective rates were 86% and 36% respectively. Both groups There was significant difference between the two groups (P <0.01). Conclusion Batroxobin is a safe and effective drug for the treatment of progressive cerebral thrombosis.